Smoking Cessation Resource Center: The GlaxoSmithKline Commitment

The GlaxoSmithKline Commitment

GlaxoSmithKline (GSK) Consumer Healthcare is a world-leading research-based pharmaceutical company with a powerful combination of skill and resources that provides a platform for delivering strong growth in today's rapidly changing health care environment.

Our mission is to improve the quality of human life by enabling people to do more, feel better, and live longer.

A Pioneering Tradition For Helping Patients Take Charge of Their Habit

With the 1996 launches of both Nicorette^® nicotine gum and NicoDerm^® CQ^® nicotine patch, GlaxoSmithKline became the first company to offer over-the-counter (OTC) nicotine replacement therapy for smokers who want to quit. In 2002, GlaxoSmithKline received US Food and Drug Administration approval for yet a third smoking cessation option-- the Commit™ nicotine lozenge. Today, GlaxoSmithKline Consumer Healthcare is the leading supplier of FDA-approved over-the-counter therapies to help people quit smoking and has pioneered efforts to make these options easily available to consumers. By understanding that when trying to quit, smokers have different needs, GlaxoSmithKline's wide range of products, commitment to education, and innovative research have helped healthcare professionals help patients quit smoking with personalized plans and significant success.